Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Opioid Abuse, Naloxone Administration, and Guidance for U.S. Pharmacists in Drug Overdose Emergencies

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

SPECIAL ADVISORY NOTICE: This CE activity describes a pharmacy protocol for dispensing naloxone via standing order which is legally acceptable in some U.S. states. While many U.S. states have adopted similar protocols to the one described in this CE activity, the authors of this activity strongly recommend that all pharmacists refer to the published standards and protocols of their respective State Boards of Pharmacy regarding naloxone dispensing, administration, and related policies before making any changes to their practice. In addition, some State Boards of Pharmacy require pharmacists to complete a certain number of hours of accredited CE on the topic(s) of naloxone standing orders and/or opiate use and abuse prior to making changes to their naloxone dispensing practices. Again, it is strongly recommended that all pharmacists check the current published requirements and protocols of their respective State Boards of Pharmacy before determining if this CE activity meets the requirements for mandatory naloxone/opiate-related CE in their respective states.

Activity Description

This ACPE-accredited CE activity is designed to provide continuing education to pharmacists who may dispense naloxone via a standing order or similar protocols allowed by their respective states. In some states, a naloxone standing order allows eligible pharmacists who have completed a certified training program in opioid overdose prevention and/or who are CPR certified to both dispense naloxone and educate patients and potential caregivers on how to properly administer naloxone.

Learning Objectives

The target audience for this activity is pharmacists. At the conclusion of this activity, participants will be able to:

  • Describe safe use of opioids for the management of chronic pain.
  • Discuss opioid overdose prevention and reducing the risk of prescription opioid overdose.
  • Outline the use of screening tools to detect opioid abuse or dependency and management of treatment-resistant patients.
  • List strategies for preventing diversion of opioid medications.
  • Describe naloxone administration techniques.
  • Describe commonly acceptable dispensing/administration protocols for naloxone standing orders.

Faculty

Ruixuan Jiang, PharmD
Post-Doctoral Fellow
Department of Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago (UIC) College of Pharmacy

Todd Lee, PharmD, PhD
Professor
Department of Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago (UIC) College of Pharmacy

Simon Pickard, BScPharm, PhD  
Professor
Department of Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago (UIC) College of Pharmacy

CE Accreditation

Release Date: 09-12-2016
Expiration Date: 09-12-2019

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and Second City Outcomes Research. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-169-H04-P has been assigned to this knowledge-based home-study CE activity (initial release date 09-12-16). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive CE credit. No partial credit will be given.

Funding

No external support has been received for this activity.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Todd Lee, Ruixuan Jiang, and Simon Pickard have no relevant commercial and/or financial relationships to disclose.

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.